Eagle Pharmaceuticals
EGRX
£0.89
Share price
15.00%
Change (1 day)
-77.86%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) - Net assets
Net assets on the balance sheet as of June 2023 : £0.19 Billion
According to Eagle Pharmaceuticals
's latest financial reports the company has £0.19 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Eagle Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $£0.19 B | 47.69% |
| 2021-12-31 | $£0.13 B | -4.21% |
| 2020-12-31 | $£0.13 B | -0.13% |
| 2019-12-31 | $£0.13 B | 7.89% |
| 2018-12-31 | $£0.12 B | -4.45% |
| 2017-12-31 | $£0.13 B | 8.15% |
| 2016-12-31 | $£0.12 B | 101.04% |
| 2015-12-31 | $£60.96 M | |
| 2014-09-30 | $£20.37 M | 1504.03% |
| 2013-09-30 | $£1.27 M | -116.98% |
| 2012-09-30 | $-£7.49 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | £55.31 B | 28,264.55% | 🇺🇸 USA |
 | £12.70 B | 6,415.51% | 🇬🇧 UK |
 | £34.14 B | 17,407.54% | 🇨🇭 Switzerland |
 | £4.42 B | 2,169.48% | 🇮🇱 Israel |
 | £4.54 B | 2,231.77% | 🇺🇸 USA |
 | £11.04 B | 5,562.43% | 🇺🇸 USA |
 | £12.67 B | 6,402.14% | 🇺🇸 USA |